Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 4 2019

Full Issue

After Securing Financial Settlement From Purdue, Oklahoma Zeroes In On Opioid Crisis 'Kingpin' Johnson & Johnson

Although Purdue Pharma has been the face of the opioid lawsuits, Johnson & Johnson has flown under the radar legally for its alleged role in the opioid crisis. But now Oklahoma's lawyers are contending that Johnson & Johnson did more than push its own pills, it also profited from the prescription opioid crisis through its ownership of a poppy producer in Australia. Other news on the epidemic comes out of Missouri and Connecticut.

Stateline: Opioid Crisis ‘Kingpin’ Is Oklahoma’s New Target In Lawsuit 

After securing a hefty financial settlement from Purdue Pharma last month, Oklahoma Attorney General Mike Hunter is training the state’s legal armaments on a much bigger pharmaceutical player: Johnson & Johnson. The company already has become a popular target. Many of the more than 1,600 opioid lawsuits in state and federal courts name Johnson & Johnson, even though its analgesic products account for less than 1% of the U.S. opioid market. (Vestal, 4/4)

St. Louis Public Radio: Metro East Veterans Sue Drug Companies Over Opioid Marketing

On Friday, Bishop and two other veterans filed suit in Illinois’ Third Judicial Circuit, which includes Madison and Bond counties, against Purdue Pharma and more than a dozen other pharmaceutical companies, alleging they marketed dangerous painkilling drugs to vets. (Hundsdorfer, 4/3)

The CT Mirror: Blacks Dying From Fentanyl At Same Rate As Whites For First Time

Fentanyl is killing black people in Connecticut at the same rate as whites for the first time since state officials began tracking the epidemic around 2012, a CT Mirror analysis has found. There is no clear consensus among experts in Connecticut as to what is driving up the death rate among African Americans. (Carlesso and Kara, 4/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF